A detailed history of Morgan Stanley transactions in Iradimed Corp stock. As of the latest transaction made, Morgan Stanley holds 47,342 shares of IRMD stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,342
Previous 72,611 34.8%
Holding current value
$2.08 Million
Previous $3.45 Million 39.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$41.17 - $47.29 $1.04 Million - $1.19 Million
-25,269 Reduced 34.8%
47,342 $2.08 Million
Q4 2023

Feb 13, 2024

BUY
$37.31 - $47.47 $716,501 - $911,613
19,204 Added 35.96%
72,611 $3.45 Million
Q3 2023

Nov 15, 2023

BUY
$43.28 - $50.3 $606,612 - $705,004
14,016 Added 35.58%
53,407 $2.37 Million
Q2 2023

Aug 14, 2023

BUY
$38.88 - $50.61 $564,848 - $735,262
14,528 Added 58.43%
39,391 $1.88 Million
Q1 2023

May 15, 2023

SELL
$28.48 - $42.14 $314,162 - $464,846
-11,031 Reduced 30.73%
24,863 $978,000
Q4 2022

Feb 14, 2023

SELL
$26.9 - $30.58 $123,659 - $140,576
-4,597 Reduced 11.35%
35,894 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$29.42 - $42.25 $267,927 - $384,770
-9,107 Reduced 18.36%
40,491 $1.22 Million
Q2 2022

Oct 27, 2022

BUY
$30.15 - $45.79 $872,510 - $1.33 Million
28,939 Added 140.08%
49,598 $1.68 Million
Q2 2022

Aug 15, 2022

BUY
$30.15 - $45.79 $872,510 - $1.33 Million
28,939 Added 140.08%
49,598 $1.68 Million
Q1 2022

Oct 27, 2022

SELL
$36.01 - $53.14 $1.04 Million - $1.54 Million
-28,939 Reduced 58.35%
20,659 $927,000
Q1 2022

May 13, 2022

SELL
$36.01 - $53.14 $299,963 - $442,656
-8,330 Reduced 28.74%
20,659 $927,000
Q4 2021

Feb 14, 2022

BUY
$32.35 - $48.27 $479,976 - $716,181
14,837 Added 104.84%
28,989 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$29.5 - $37.21 $417,484 - $526,595
14,152 New
14,152 $475,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $552M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.